Mahindra & Mahindra, Titan and Infosys to see some action today

Titan Company Ltd. | Diamond & Jewellery | Consumer Durables | BSE: 500114 | NSE: TITAN

12 Apr 2021 Evaluate

Mahindra & Mahindra (M&M) is planning to put fresh investments to the tune of Rs 3000 crore on its Electric Vehicles (EV) business in the next three years, while it looks for more alliances and partnerships in the vertical. The company is working on developing on an EV platform by combining capabilities of its operations across the globe, including Detroit and Italy.

Titan Company’s subsidiary company -- Tanishq has unveiled a new brand proposition for its wedding exclusive sub-brand 'Rivaah' - Jewel for every tradition. The new proposition from Rivaah by Tanishq communicates the meaning and significance of every ritual and jewellery the bride wears. Even as there is a general nervousness in the gems and jewellery industry about the Covid related restrictions in Maharashtra impacting the wedding season demand, Tanishq is betting big on the rest of the markets for the wedding jewellery.

Infosys’ Board of Directors is going to consider on proposal for buyback of fully paid-up equity shares of the company. The outcome of the Board meeting will be disseminated to the stock exchanges after conclusion of the Board meeting on April 14, 2021, in accordance with the applicable provisions of the SEBI LODR Regulations.

Castrol India and Ki Mobility Solutions have entered into an exclusive supply arrangement in India wherein Castrol shall supply lubricant products to Ki Mobility's multi-brand workshops.

Century Plyboards (India) has introduced a pioneering solution for its customers by launching the use of Firewall Technology in manufacturing its products. Firewall technology ensures that its customers get critical time to act and be safe in case of fire. Firewall Technology is the outcome of arduous and indigenous research work done by the organization.

Natco Pharma’s marketing and distribution partner -- Alvogen Pine Brook LLC, has received tentative approval for Abbreviated New Drug Application (ANDA) Ibrutinib Tablets 560mg, 420mg, 280mg and 140mg strengths (generic for Imbruvica), from the U.S. Food and Drug Administration (USFDA).

Transwarranty Finance has raised Rs 25 lakh through Secured Redeemable Non Convertible Debentures (NCDs) under Thirteenth Tranche/Series M/2020-21, on private placement basis.

Titan Co Share Price

4513.40 204.90 (4.76%)

08-May-2026 16:59 View Price Chart

Peers

Company Name	CMP
Titan Co	4513.40
Kalyan Jewell.India	424.65
Rajesh Exports	121.80
Senco Gold	365.45
Thangamayil Jeweller	4247.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.